Vendrami, C.
Marques-Vidal, P. http://orcid.org/0000-0002-4548-8500
Gonzalez Rodriguez, E. http://orcid.org/0000-0001-6512-6008
Hans, D. http://orcid.org/0000-0003-1826-5958
Waeber, G.
Lamy, O. http://orcid.org/0000-0003-3684-2376
Funding for this research was provided by:
Université de Lausanne
Article History
Received: 23 April 2021
Accepted: 21 July 2021
First Online: 19 August 2021
Change Date: 15 November 2021
Change Type: Update
Change Details: The original version was revised due to an update in the funding note.
Declarations
:
: The CoLaus and OsteoLaus studies were approved by the Institutional Ethics Committee of the University of Lausanne, which afterwards became the Ethics Commission of Canton Vaud (Commission cantonale d’éthique de la recherche sur l’être humain. Available from: ExternalRef removed). The studies were performed in agreement with the Helsinki Declaration and its former amendments, and in accordance with the applicable Swiss legislation. All participants gave their written informed consent before entering the study. Informed consent was obtained from all participants involved in the study.
: Informed consent was obtained from all participants involved in the study.
: Colin Vendrami, Pedro Marques-Vidal, Elena Gonzalez Rodriguez, Gérard Waeber, and Olivier Lamy declare that they have no conflict of interest related to this manuscript. Didier Hans is a co-owner of the TBS patent and holds stock options and royalties in the Medimaps group.
: Not applicable.